Stock screenerAll disclosures → EDGAR →
QCLS
Conviction 0HealthcareScan · Mon, Aug 10, 2026QCLS$2.88-1.54%
ResistanceSupportVol 14Vol MA14 176.72K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.88
Change-1.54%
Gap+0.00%
Rel volume0.53×
Avg volume173.31K
Avg $ vol523.85K
SMA 203.08
SMA 503.53
SMA 2003.91
Price vs 50-18.64%
Price vs 200-26.48%
MA stackbearish
50/200 cross—
Supertrenddown · 3.36
RSI (14)41
MACD hist0.01
MACD crossbull · 1d
Stoch %K / %D40 / 37
ADX (14)22
+DI / −DI15 / 22
RSI divergence—
MACD divergence—
ATR %+8.22%
ADR %7.37%
52w high6.92
52w low2.51
From 52w high-58.45%
Above 52w low+14.54%
New 52w highNo
SqueezeOff
Bollinger width40.31%
%B0.34
Donchian pos34.63%
Donchian high3.58
Donchian low2.50
AVWAP (52w high)5.17
vs AVWAP high-44.43%
AVWAP (52w low)5.56
vs AVWAP low-48.32%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d0.53×
Avg vol (14d)176.72K
Avg vol (20d)173.31K
Avg $ vol (20d)523.85K
Market cap22.58M
RS 3m (vs SPY)-28.04%
RS 6m (vs SPY)-31.16%
RS line new highNo
Trend template—
Technical rank9.8
1 week+4.55%
1 month-20.36%
3 months-23.74%
6 months-27.03%
1 year—
YTD-32.03%
P/E-1.94
P/B1.09
P/S14.32
P/FCF-2.47
EPS-8.66
Div yield—
ROE-56.12%
ROA-30.36%
Debt/Eq0.01
Current3.71
EV/EBITDA-2.22
Gross margin30.36%
Net margin-737.28%
Rev growth-5.32%
EPS growth50.22%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value21.76M
Revenue-1.89K
Net income-1.24M
Gross profit-379.06K
Free cash flow-9.13M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out7.85M
Employees2
ListedMon, Apr 19, 2021
Free float7.79M
Float %99.2%
Short interest1.6M
Days to cover7.1d
Short volume21.9%
Squeeze score65 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank9.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.12
Support2.86
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in QCLS
No recent disclosed trades by Congress in QCLS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in QCLS
No recent insider (Form 4) filings in QCLS. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in QCLS · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.